CA2824591C - High protein nutritional compositions and methods of making and using same - Google Patents

High protein nutritional compositions and methods of making and using same Download PDF

Info

Publication number
CA2824591C
CA2824591C CA2824591A CA2824591A CA2824591C CA 2824591 C CA2824591 C CA 2824591C CA 2824591 A CA2824591 A CA 2824591A CA 2824591 A CA2824591 A CA 2824591A CA 2824591 C CA2824591 C CA 2824591C
Authority
CA
Canada
Prior art keywords
protein
omega
source
patient
amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2824591A
Other languages
English (en)
French (fr)
Other versions
CA2824591A1 (en
Inventor
Norman Alan Greenberg
Doug Bolster
Zamzam Kabiry ROUGHEAD (Fariba)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Societe des Produits Nestle SA
Original Assignee
Nestec SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45554910&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2824591(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestec SA filed Critical Nestec SA
Publication of CA2824591A1 publication Critical patent/CA2824591A1/en
Application granted granted Critical
Publication of CA2824591C publication Critical patent/CA2824591C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pediatric Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
CA2824591A 2011-02-02 2012-01-26 High protein nutritional compositions and methods of making and using same Active CA2824591C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161438804P 2011-02-02 2011-02-02
US61/438,804 2011-02-02
PCT/US2012/022726 WO2012106179A1 (en) 2011-02-02 2012-01-26 High protein nutritional compositions and methods of making and using same

Publications (2)

Publication Number Publication Date
CA2824591A1 CA2824591A1 (en) 2012-08-09
CA2824591C true CA2824591C (en) 2019-02-05

Family

ID=45554910

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2824591A Active CA2824591C (en) 2011-02-02 2012-01-26 High protein nutritional compositions and methods of making and using same

Country Status (14)

Country Link
US (1) US9930908B2 (enExample)
EP (1) EP2670262B2 (enExample)
JP (1) JP6034805B2 (enExample)
CN (1) CN103347403B (enExample)
AU (3) AU2012212591A1 (enExample)
BR (1) BR112013019677B1 (enExample)
CA (1) CA2824591C (enExample)
ES (1) ES2882806T5 (enExample)
MX (1) MX2013009007A (enExample)
PH (1) PH12013501433A1 (enExample)
RU (1) RU2013140443A (enExample)
SG (1) SG191428A1 (enExample)
WO (1) WO2012106179A1 (enExample)
ZA (1) ZA201306543B (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103347403B (zh) 2011-02-02 2016-04-20 雀巢产品技术援助有限公司 高蛋白质营养组合物及其制备和应用方法
US9820504B2 (en) 2013-03-08 2017-11-21 Axiom Foods, Inc. Rice protein supplement and methods of use thereof
WO2014138304A1 (en) 2013-03-08 2014-09-12 Axiom Foods, Inc., Rice protein supplements
EP3082465A2 (en) * 2013-12-19 2016-10-26 Abbott Laboratories Nutritional composition comprising hydrolyzed protein
CN105212042A (zh) * 2014-06-30 2016-01-06 罗汉斐 一种小麦发酵营养食品及其制作方法
EP3634155A4 (en) 2017-05-12 2021-02-17 Axiom Foods Inc. RICE PRODUCTS AND SYSTEMS AND PROCESSES FOR THEIR PRODUCTION
US10806169B2 (en) 2018-05-15 2020-10-20 Kate Farms, Inc. Hydrolyzed pea protein-based nutrient composition
US12558370B2 (en) * 2018-06-12 2026-02-24 Kate Farms, Inc. Intact pea protein-based nutrient composition
US20220053796A1 (en) * 2018-06-14 2022-02-24 Mars, Incorporated Composition for supporting animal with cancer
US11058139B2 (en) * 2018-07-03 2021-07-13 Kerri Ann Langhorne Recovery supplement for horses
JP7682790B2 (ja) 2018-11-20 2025-05-26 フォンテラ コ－オペレイティブ グループ リミティド 乳製品およびプロセス
FR3093427B1 (fr) * 2019-03-05 2021-03-05 Mativa Tech Composition pour son utilisation dans la prévention et/ou le traitement de la dysbiose
US20200375937A1 (en) * 2019-05-31 2020-12-03 Société des Produits Nestlé S.A. Mct-based nutrition blend for providing health benefits in animals
AR120346A1 (es) * 2019-10-31 2022-02-09 Idemitsu Kosan Co Agente para suprimir la resistencia a la insulina en rumiantes

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6140304A (en) 1988-09-28 2000-10-31 Eicotech Corporation Method of and nutritional and pharmaceutical compositions for reduction of hyperinsulinemia
US5714472A (en) † 1993-12-23 1998-02-03 Nestec Ltd. Enternal formulation designed for optimized nutrient absorption and wound healing
WO1995026646A1 (en) † 1994-04-01 1995-10-12 Abbott Laboratories Nutritional product for treatment of ulcerative colitis and use thereof
US5776913A (en) 1995-10-10 1998-07-07 Colgate Palmolive Company Therapeutic diet for metabolic abnormalities found in animals with lymphoma
DE69912441T2 (de) 1998-08-19 2004-08-19 Skyepharma Canada Inc., Verdun Injizierbare wässerige propofoldispersionen
US20040121044A1 (en) * 2001-03-14 2004-06-24 John Tiano Nutritional product with high protein, low carbohydrate content and good physical stability
EP1383445A4 (en) 2001-03-20 2005-04-13 Cydex Inc FORMULATIONS WITH PROPOFOL AND A SULFOALKYL ETHER CYCLODEXTRIN
SE526943C2 (sv) 2002-08-26 2005-11-22 Indevex Ab Födoämneskompositionsprodukt
US20040225022A1 (en) † 2003-05-09 2004-11-11 Desai Neil P. Propofol formulation containing reduced oil and surfactants
JP4699901B2 (ja) * 2003-09-02 2011-06-15 ジェレックスインターナショナル株式会社 体脂肪代謝機能と燃焼エネルギーの活用機能とを備えているダイエット用添加物質
US7759507B2 (en) * 2003-09-05 2010-07-20 Abbott Laboratories Lipid system and methods of use
EP1723951A1 (en) † 2005-04-21 2006-11-22 N.V. Nutricia Nutritional supplement with oligosaccharides for a category of HIV patients
CN1997425B (zh) * 2004-07-01 2010-10-13 雀巢技术公司 犬骨关节炎饮食配方
EP1797891A4 (en) * 2004-09-22 2011-03-16 Ajinomoto Kk TOTAL ENTERAL FOOD COMPOSITION
JP2009506012A (ja) 2005-08-26 2009-02-12 ネステク ソシエテ アノニム 肥満患者の栄養素
US20070166411A1 (en) * 2005-12-16 2007-07-19 Bristol-Myers Squibb Company Nutritional supplement containing long-chain polyunsaturated fatty acids
EP1971230A2 (en) † 2006-01-09 2008-09-24 Nestec S.A. Treatment of stressed patients
RU2420210C2 (ru) * 2006-03-23 2011-06-10 Нестек С.А. Высококалорийная питательная добавка
GB0612671D0 (en) 2006-06-27 2006-08-09 Shs Int Ltd Nutritional formulation
EP2374452B1 (en) † 2008-12-05 2019-07-24 Ajinomoto Co., Inc. Nutrient composition
CN103347403B (zh) † 2011-02-02 2016-04-20 雀巢产品技术援助有限公司 高蛋白质营养组合物及其制备和应用方法

Also Published As

Publication number Publication date
RU2013140443A (ru) 2015-03-10
SG191428A1 (en) 2013-08-30
CA2824591A1 (en) 2012-08-09
CN103347403A (zh) 2013-10-09
AU2017225011A1 (en) 2017-09-28
MX2013009007A (es) 2013-08-29
CN103347403B (zh) 2016-04-20
BR112013019677A2 (pt) 2017-03-21
EP2670262B1 (en) 2021-06-30
BR112013019677B1 (pt) 2019-10-08
WO2012106179A1 (en) 2012-08-09
AU2017225011B2 (en) 2019-07-18
PH12013501433A1 (en) 2013-09-09
JP6034805B2 (ja) 2016-11-30
ZA201306543B (en) 2015-03-25
JP2014505702A (ja) 2014-03-06
AU2016201327A1 (en) 2016-03-17
ES2882806T3 (es) 2021-12-02
EP2670262A1 (en) 2013-12-11
EP2670262B2 (en) 2025-10-15
US9930908B2 (en) 2018-04-03
ES2882806T5 (en) 2026-03-13
AU2012212591A1 (en) 2013-07-25
US20140308390A1 (en) 2014-10-16

Similar Documents

Publication Publication Date Title
AU2017225011B2 (en) High protein nutritional compositions and methods of making and using same
US9538778B2 (en) Stable thickener formulations
US20130210715A1 (en) Nutritional compositions and methods for weaning from parenteral nutrition to enteral nutrition
AU2012241895A1 (en) Nutritional compositions including branched chain fatty acids for wound healing

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20161221

MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 13TH ANNIV.) - STANDARD

Year of fee payment: 13

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20241207

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20241207

MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 14TH ANNIV.) - STANDARD

Year of fee payment: 14

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20251202

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20251202